Most product teams don’t need more user signals. They need a decision they can defend.
The meeting has a dashboard, a support ticket summary, a designer’s annotations, notes from a recent customer call, and a slide with three competing hypotheses.
The PM thinks onboarding is too long. The lead designer thinks the interface is too complex. The growth lead wants to test a new email sequence. Someone from leadership wants a copy test on the hero headline. A product designer who attended a conference recently believes the product simply feels harder to use than alternatives.
All of them are looking at the same signals. None of them are looking at the same problem.
The team will make a decision in this meeting. They will allocate sprint capacity, engineering time, and design attention toward one of these directions. They will do this without knowing which direction addresses the actual cause.
That is the problem this article is about.
You Have Data. You Don’t Have a Diagnosis.
Most product teams are not short on signals. They have conversion funnels, heatmaps, support tickets, feature requests, NPS trends, user quotes from customer calls, and a backlog of hypotheses accumulated across multiple planning cycles. In many teams, the amount of data has grown steadily. The capacity to interpret it has not kept pace.
There is a useful distinction between a symptom and a diagnosis. A symptom tells the team that something is happening: activation is lower than expected, users are dropping off at a specific step, a feature shipped and did not move behavior. A diagnosis goes further — it explains what is happening, why it may be happening, and what that implies for the next decision.
Most teams are fluent in symptoms. Data without diagnosis — a full dashboard without a clear reading of what those signals mean for the decision at hand — is still a weak foundation for product work. The harder capability is moving from “users are not completing onboarding” to a defensible interpretation of why, and from that interpretation, to a product decision that addresses the cause rather than the visible signal.
Without that move, teams are not making product decisions based on comprehensive evidence. They are making product decisions based on intuition about evidence.
The Misunderstanding That Makes It Worse
Part of the problem is how UX Research gets defined in practice. In many organizations, research means collecting feedback: running interviews before a launch, surveying users after a release, or pulling quotes from customer success calls to include in a product brief.
This framing turns research into a collection activity. And collection, on its own, does not produce what product teams actually need.
A user quote is not an insight. An observation is not a recommendation. Feedback is not research. Data is not interpretation.
When research is treated primarily as collection, the interpretation step never gets deliberately allocated. It gets compressed into whoever presents the findings, rushed into a list of takeaways, or replaced by the instincts of the most senior person in the room. The gap between what users said and what that means for the next product decision remains open — but no one owns it.
Four Compounding Losses of Weak UX Research
These losses do not happen separately. They compound. Weak interpretation leads to a weak problem definition. A weak problem definition generates results that are hard to learn from. Poor traceability slows strategic learning. And by the time the financial cost becomes visible, the organization rarely calls it a research problem. It calls it roadmap risk, execution risk, or market risk.
Loss 1: Time spent solving the wrong problem.
Teams can move fast while addressing symptoms instead of causes. A drop-off in onboarding reads as an onboarding problem, so the team shortens the flow, removes a step, and redesigns screens. The work is real. The velocity is real. But the underlying issue — that users may not understand why completing onboarding is worth their time — remains intact. Weeks or months of PM, designer, and engineering attention are applied to the visible signal while the actual problem continues to affect activation.
Loss 2: Learning that cannot be traced back to a clear hypothesis.
Without traceability, teams may know what happened but not what it means. A headline test improves trial signups. But if no behavioral hypothesis was articulated before the test, the result only says which headline attracted more signups in that context. It does not say whether the team clarified value, reduced uncertainty, or simply increased entry into a broken downstream experience. A week later, session recordings show new users moving through setup without reaching a first meaningful action. Support tickets from recent signups reflect the same confusion that existed before the test. The conversion metric moved. The underlying problem did not. Teams keep testing, shipping, and redesigning — but without a chain between hypothesis, observation, and interpretation, the organization accumulates results without explanations.
Loss 3: Opportunity cost while competitors learn faster.
While one team debates whether the issue is copy, pricing, onboarding length, or a missing feature, another team may be learning more precisely — what users value, what they mistrust, what they compare, what criteria they use to decide, and what they need in order to move forward. Good UX Research does not guarantee that a team will win. But weak interpretation slows strategic learning. The team may still be moving fast, but speed matters less when the learning loop is pointed at the wrong problem. Late corrections are more expensive than early clarity.
Loss 4: Money allocated to the wrong problem, for the wrong reason, at the wrong time.
This is where the previous losses become financial. The cost of weak interpretation rarely appears as a research problem. It appears as underused features, repeated redesigns of the same flows, shallow experiments, roadmap items that need to be revisited, engineering cycles applied to poorly diagnosed problems, campaigns built on value propositions users do not recognize, and pricing changes made before understanding risk, trust, or decision criteria.
The evidence points in a consistent direction. Pendo’s 2019 Feature Adoption Report found that 80% of features in the average software product are rarely or never used, with an estimated $29.5 billion potentially invested in features that see minimal adoption among publicly traded cloud software companies. CB Insights’ analysis of startup failure reasons found that poor product-market fit appeared in 43% of the cases where failure reasons could be identified. Research on software development waste, presented at ICSE, identifies “building the wrong feature or product” as a form of waste, with observed causes including not doing user research, validation, or testing — as well as ignoring feedback or working on low user-value features.
None of these figures prove that weak UX Research caused the waste. But the shared pattern is not that teams need more data. The shared pattern is that building, prioritizing, and investing without a defensible interpretation of user value can become expensive very quickly.
Why These Losses Stay Invisible
Weak research rarely appears as a research problem in retrospectives. It appears as a failed A/B test, another redesign of the same flow, a feature that shipped but did not change behavior, a roadmap item that needed revisiting, a campaign that attracted attention but not adoption, or internal disagreement that returned after the research presentation ended.
The cost is not labeled as research cost. It shows up later as wasted roadmap, repeated redesign, shallow experiments, delayed learning, and decisions that have to be remade. By the time the pattern is visible, the teams responsible have moved on to new priorities. The losses compound quietly, across cycles, under different names.
What Good UX Research Actually Does
Consider the onboarding scenario from the opening. The assumption is that the flow is too long. A weaker approach asks users which step is most confusing and reports back the most common answer.
Good UX Research starts differently. It asks what decision the user is making at the drop-off point — and whether users understand the steps, or understand what completing them is worth. It looks for signals of low perceived value, missing decision criteria, or an unclear path to a first meaningful outcome. It asks what evidence would change the product direction.
The evidence may show that users understand each step individually. What they cannot see is how finishing setup today connects to the result they came for. The implication is not to remove steps — it may be to sequence them around demonstrated value rather than system requirements.
That is the reasoning chain in practice:
real product problem → user signal → evidence → hypothesis → interpretation → implication → better-informed product decision
Good UX Research does not begin with a method. It begins with the decision the team needs to make. Before any interview guide is written or test scenario is designed, the relevant questions are: What uncertainty is blocking a decision that should be made? What evidence would meaningfully change the direction?
From that starting point, good research makes internal assumptions explicit, chooses methods according to the type of uncertainty, and carefully separates what users say from what they do, evidence from interpretation, and interpretation from implication. It helps the team decide what to build, test, redesign, pause, or investigate next — and makes that decision traceable, so it can be defended, evaluated, and learned from.
Recommendation Robustness
A robust recommendation is not merely plausible. It is visible — the reasoning behind it is open to examination.
Consider a product team reviewing a pricing page with below-target conversion. A weak recommendation says: simplify the pricing page.
A traceable recommendation says something different: users appear to understand the pricing tiers but may lack criteria for selecting the right plan. The friction may be decision confidence, not visual complexity. The product implication is to support plan selection through use-case framing, clearer consequences of each choice, reversibility, and risk reduction.
Those two recommendations lead to different investments. The first allocates effort to layout. The second allocates effort to the decision the user is trying to make at the moment that determines whether they move forward or not. Only the second is grounded in an interpretation of behavior rather than a reading of the symptom. And only the second can be examined, challenged, or updated when new evidence arrives.
Financial Impact Without Overpromising
Good UX Research does not guarantee revenue growth, conversion improvement, retention, or ROI. Any framing that promises those outcomes overstates what research can deliver and misrepresents the role it plays in a product organization.
Good UX Research can have financial relevance because it improves the quality of decisions about where product investment goes.
It can help reduce the risk of building features based on literal requests rather than underlying needs; redesigning flows that were not the real source of hesitation; optimizing conversion before understanding the decision users are trying to make; adjusting pricing when the deeper issue is perceived value or risk; or running experiments without a behavioral hypothesis that could explain the result either way.
The financial value of UX Research is not only in what it helps a team build. It is also in what it helps a team avoid building too soon, for the wrong reason, or for the wrong user.
Closing
Good UX Research does not protect product teams from difficult decisions. It does not replace product judgment. What it does is make the path from user signal to product decision more traceable — so that when a team commits to a direction, that commitment rests on interpreted evidence rather than organized intuition.
Most product teams are not one more dashboard, user quote, or A/B test away from clarity. They are one better comprehensive and structured interpretation away. The data is often already there. What is missing is the analytical step between observation and recommendation — the step where evidence becomes a position the team can actually defend.
The real value is not simply knowing more about users. It is being able to trace a product decision back to the evidence and interpretation that made it defensible.
Soreon is a boutique UX Research consultancy helping product teams turn explicit and implicit user signals into clearer, traceable product decisions.
